17:05 EST Elicio Therapeutics (ELTX) files to sell 103,225 shares of common stock for holders
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ELTX:
- Elicio Therapeutics announces additional data from Phase 2 AMPLIFY-7P trial
- Elicio announces preliminary analysis from Phase 2 AMPLIFY-7P trial
- Elicio Therapeutics announces investigator-initiated Phase 1 trial of ELI-002 7P
- Elicio Therapeutics reports inducement grants
- Elicio Therapeutics Announces Promising Phase 2 Vaccine Results